Table 1 Demographic and laboratory data
From: Is podocytopathy another image of renal affection in p-SLE?
Group I Lupus Nephritis (LN) cases n = 79 | Group II Lupus Podocytopathy (LP) cases n = 7 | Test | P-value | |
|---|---|---|---|---|
Age (years) (Mean ± SD) | 12.24 ± 3.31 | 13.60 ± 2.30 | t: 1.069 | 0.24 |
Female % (n%) F/M | 88.6% 7.8/1 | 100% 7/0 | X2: 0.608 | 0.71 |
SLEDAI (Median, IQR) | 22 (15–27) | 16 (12–22) | U: 48.182 | 0.001* |
Serum creatinine (mg %) (Mean ± SD) (Normal: 0.3–0.7 mg %) | 1.05 ± 0.53 | 1.66 ± 0.67 | t: 5.488 | 0.001* |
24 h urinary proteins (g) (Mean ± SD) (Normal: < 0.15 g) | 1.10 ± 0.79 | 3.41 ± 0.30 | t: 6.324 | 0.001* |
C3 (mg %)(Mean ± SD) (Normal: 90–160 mg %) | 47.0 ± 10.13 | 75.40 ± 12.70 | t: 24.611 | 0.001* |
C4 (mg %)(Mean ± SD) (Normal: 10–40 mg %) | 4.25 ± 2.90 | 13.60 ± 5.68 | t: 70.240 | 0.001* |
Anti-ds DNA (IU/ml) (Mean ± SD) (Normal: 30–70 IU/ml) | 423.75 ± 43.20 | 230.80 ± 66.44 | t: 3.672 | 0.002* |